Document Detail


Associations of Serum Sclerostin and Polymorphisms in the SOST Gene with Bone Mineral Density and Markers of Bone Metabolism in Postmenopausal Chinese Women.
MedLine Citation:
PMID:  24423318     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Objective: The aims of this study were to (1) evaluate the association of serum sclerostin with bone mineral density (BMD) and markers of bone metabolism in postmenopausal Chinese women and (2) observe the relationships of single nucleotide polymorphisms (SNPs) within the sclerostin (SOST) gene with serum sclerostin, BMD, and markers of bone metabolism. Design: A cross-sectional study was conducted with 703 postmenopausal Chinese women. Ten tagging SNPs (rs1234612, rs1513670, rs1634330, rs1708635, rs2023794, rs7220711, rs74252774, rs851057, rs851058, and rs865429) of the SOST gene were genotyped. Serum sclerostin and markers of bone metabolismwere measured, including serum intact parathyroid hormone, 25-hydroxyvitamin D [25(OH)D], procollagen type 1 N-terminal propeptide (P1NP), and β-CrossLaps of type I collagen containing cross-linked C-telopeptide (β-CTX). The BMD of the lumbar spine and proximal femur were measured by dual-energy X-ray absorptiometry. Results: Serum sclerostin was positively correlated with BMD at lumbar spine, femoral neck, total hip and with serum 25(OH)D (all P<0.01), but negatively correlated with β-CTX (P<0.01). The significant relationships between serum sclerostin and BMD and with serum β-CTX persisted even after adjustments for age, BMI and serum 25(OH)D (all P<0.01). However, there was no correlation between serum sclerostin and age or serum P1NP. We failed to identify a significant association between the SNP, haplotypes of SOST and BMD, serum sclerostin, or markers of bone metabolism. Conclusion: Our results suggested that serum sclerostin was positively correlated with the BMD at lumbar spine, femoral neck, total hip and with serum 25(OH)D but was negatively correlated with serum β-CTX. Genetic polymorphisms of SOST may not be a major contributor to variations in the serum sclerostin or BMD in postmenopausal Chinese women.
Authors:
Jinwei He; Hao Zhang; Chun Wang; Zeng Zhang; Hua Yue; Weiwei Hu; Jiemei Gu; Wenzhen Fu; Yunqiu Hu; Miao Li; Yujuan Liu; Hui Zheng; Zhenlin Zhang
Related Documents :
15072888 - Ethnic differences in distribution of serum prostate-specific antigen: a study in a hea...
1349918 - Serum dipeptidyl peptidase (dpp) iv activity in hamster buccal pouch carcinogenesis wit...
1177458 - Simultaneous determination of plasma and urinary carcinoembryonic antigen levels.
7541358 - Pretreatment with chlormadinone acetate eliminates testosterone surge induced by a lute...
328018 - Preliminary observations on valproic acid kinetics in patients with epilepsy.
1418848 - Natriuretic hormones in young hypertensives and in young normotensives with or without ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-1-1
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  -     ISSN:  1945-7197     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2014 Jan 
Date Detail:
Created Date:  2014-1-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  -    
Other Details:
Languages:  ENG     Pagination:  jc20132086     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expression of a mitochondrial progesterone receptor (PR-M) in leiomyomata and association with incre...
Next Document:  Absence of Central Circadian Pacemaker Abnormalities in Humans With Loss of Function Mutation in Pro...